Oxagen
London, England, United Kingdom
About Oxagen
Oxagen Limited, a biopharmaceutical company, provides drug discovery and development solutions. It offers molecule drugs for the treatment of asthma, autoimmune disease, inflammatory bowel, psoriasis, allergy, and rheumatoid arthritis diseases. Oxagen Limited was founded in 1997 and is based in Abingdon, the United Kingdom.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $130.7M
- Funding stage: Late Stage Venture
- Last round: Series C (Nov 2009)
- Website: oxagen.co.uk
- Phone: 44 12 3584 1561
Industries & Categories
Biopharma, Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/oxagen-2596135 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.